A detailed history of Mufg Securities Emea PLC transactions in Catalent, Inc. stock. As of the latest transaction made, Mufg Securities Emea PLC holds 170,999 shares of CTLT stock, worth $10.1 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
170,999
Previous 241,800 29.28%
Holding current value
$10.1 Million
Previous $13.6 Million 23.82%
% of portfolio
0.41%
Previous 0.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$56.16 - $60.96 $3.98 Million - $4.32 Million
-70,801 Reduced 29.28%
170,999 $10.4 Million
Q2 2024

Jul 31, 2024

BUY
$53.58 - $57.02 $13 Million - $13.8 Million
241,800 New
241,800 $13.6 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mufg Securities Emea PLC Portfolio

Follow Mufg Securities Emea PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.